Sandbox ap: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
<pre>
*Post exposure prophylaxis <ref name="pmid24447897">{{cite journal| author=Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT et al.| title=Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. | journal=Emerg Infect Dis | year= 2014 | volume= 20 | issue= 2 | pages=  | pmid=24447897 | doi=10.3201/eid2002.130687 | pmc=PMC3901462 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24447897  }} </ref>
__NOTOC__
:*Preferred regimen : [[ciprofloxacin]], 500 mg every 12 h {{or}} [[doxycycline]], 100 mg every 12 h {{or}} [[levofloxacin]], 750 mg every 24 h {{or}} [[moxifloxacin]], 400 mg every 24 h {{or}} [[clindamycin]], 600 mg every 8 h
{{SI}}
:*Alternatives for penicillin-susceptible strains [[amoxicillin]], 1 g every 8 h {{or}} [[penicillin]] VK, 500 mg every 6 h
{{CMG}}; {{AE}} {{AV}}
 
{{SK}}
 
==Overview==
{{PAGENAME}} refers to a regimen consisting of xxx used to treat xxx.
 
==Regimen==
{{chemo|x|xx}}
 
{{chemo|x|xx}}
 
{{chemo|x|xx}}
 
{{chemo|x|xx}}
 
==Indications==
 
 
==References==
{{Reflist|2}}
 
[[Category:Chemotherapy regimens]]
 
</pre>

Revision as of 18:02, 9 June 2015

  • Post exposure prophylaxis [1]
  1. Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT; et al. (2014). "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults". Emerg Infect Dis. 20 (2). doi:10.3201/eid2002.130687. PMC 3901462. PMID 24447897.